- Report
- April 2022
- 307 Pages
Global
From €5307EUR$5,550USD£4,548GBP
- Report
- October 2022
- 79 Pages
North America
From €1434EUR$1,500USD£1,229GBP
- Book
- September 2022
- 304 Pages
- Book
- September 2021
- 304 Pages
Thrombocytosis is a hematological disorder characterized by an abnormally high platelet count in the blood. Platelets are small cell fragments that help the blood to clot. Thrombocytosis can be caused by a variety of conditions, including certain types of cancer, anemia, and inflammatory diseases. It can also be caused by certain medications, such as chemotherapy drugs. Symptoms of thrombocytosis include fatigue, dizziness, and shortness of breath. Treatment for thrombocytosis typically involves medications to reduce the platelet count, as well as lifestyle changes to reduce the risk of complications.
There are several companies that specialize in the treatment of thrombocytosis. These include Novartis, Pfizer, and Bristol-Myers Squibb. Other companies that offer products and services related to thrombocytosis include Roche, Amgen, and Merck. Show Less Read more